SVS Management Ltd Pharmaceutical Import Profile — Poland (DGFT 2022–2026)

Name: SVS Management Ltd Pharmaceutical Import Records from India — 2 Products, $8.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

SVS Management Ltd — Pharmaceutical Importer Profile (2026) | 2 Products, $8.7K Trade | TransData Nexus

Who Are the Verified Indian Suppliers to SVS Management Ltd?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Shri Dharmasthala Manjunatheshwara Baishajya Prati	$45.2K	135	48.7%
Yaksha India Expo	$42.8K	80	46.0%
New Udaya Pharmacy & Ayurvedic Laboratories	$4.9K	18	5.3%

SVS Management Ltd sources from 3 verified Indian suppliers across 232 distinct formulations. Total import value: $92.9K across 233 shipments.

What Formulations Does SVS Management Ltd Import?

Formulation	Value	Ships
Ayurvedic manasmithra vati 100	$5.1K	1
Shiva gutika , batch no-svt020 100 pills 780 ML pet container-36units x 9boxesmfg.date- 10/2023, exp. date- 09/2026	$2.9K	1
Shiva gutika batch no-svt015100 pills	$2.8K	1
Herbal ksheerbala tabs	$2.7K	1
Herbal mansa mithra	$2.3K	1
Herbal h-91	$1.9K	1
Ayurvedic ksheerbala CAPS	$1.9K	1

What Products Does SVS Management Ltd Import?

Top Products by Import Value

1Gutika$6.2K 2Ghrita$2.6K

SVS Management Ltd Therapeutic Categories — 1 Specializations

SVS Management Ltd imports across 1 therapeutic categories, with Ayurvedic & Herbal Products (100.0%), representing the largest segments. The portfolio is concentrated — top 5 products = 100% of total imports.

Ayurvedic & Herbal Products

2 products · 100.0% · $8.7K

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Gutika	Ayurvedic & Herbal Products	$6.2K	4	4.9%	4
2	Ghrita	Ayurvedic & Herbal Products	$2.6K	9	0.6%	17

Key Metrics

Total Import Value$8.7K

Products2

Shipments13

Categories1

CountryPoland

#1 Rankings0

Indian Suppliers3

Formulations232

Top Categories

Ayurvedic & Herbal Products100.0%

Indian Suppliers

Last updated: March 28, 2026

SVS Management Ltd — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

SVS Management Ltd is a pharmaceutical importer based in Poland, specializing in the acquisition of finished pharmaceutical formulations from India. The company has engaged in 13 shipments, importing two distinct products across a single therapeutic category, Ayurvedic & Herbal Products. The total import value from India amounts to $9,000 USD. The primary products imported include Gutika, valued at $6,000 USD, and Ghrita, valued at $3,000 USD. These products are sourced from three verified Indian suppliers: Shri Dharmasthala Manjunatheshwara Baishajya Prati, Yaksha India Expo, and New Udaya Pharmacy & Ayurvedic Laboratories. The company's operations are characterized by a high degree of supplier concentration, with the top five products accounting for 100% of the import portfolio. This suggests a focused approach to sourcing, potentially leveraging specialized supplier relationships to meet specific market demands in Poland.

2Distribution Network

While specific details regarding SVS Management Ltd's warehouse locations and logistics capabilities are not publicly disclosed, the company's import activities indicate a reliance on established distribution channels within Poland. The importation of Ayurvedic & Herbal Products from India suggests that the company may collaborate with local distributors or wholesalers to facilitate the storage and distribution of these products. Given the specialized nature of Ayurvedic products, it is likely that SVS Management Ltd partners with entities experienced in handling such goods, ensuring compliance with Polish regulations and meeting market demand.

Supplier Relationship Intelligence — SVS Management Ltd

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

SVS Management Ltd's sourcing strategy exhibits a high degree of concentration, with the top five products accounting for 100% of the import portfolio. This indicates a focused approach to procurement, potentially aimed at maintaining strong supplier relationships and ensuring product consistency. The reliance on a limited number of suppliers—three verified Indian suppliers—suggests a strategic choice to streamline operations and possibly negotiate favorable terms. However, this concentration also introduces risks associated with supply chain disruptions, such as potential delays or quality issues from a single supplier. To mitigate these risks, it would be prudent for SVS Management Ltd to consider diversifying its supplier base and exploring additional product lines within the Ayurvedic & Herbal Products category.

2Supply Chain Resilience

The resilience of SVS Management Ltd's supply chain is closely tied to the stability and reliability of its Indian suppliers. The company's current sourcing strategy, characterized by a high degree of concentration, may expose it to risks associated with supply chain disruptions, such as delays or quality issues from a single supplier. To enhance supply chain resilience, it would be prudent for SVS Management Ltd to consider diversifying its supplier base and exploring additional product lines within the Ayurvedic & Herbal Products category. This approach would not only mitigate potential risks but also provide a broader range of products to meet the diverse needs of the Polish market.

3Strategic Implications

SVS Management Ltd's concentrated sourcing strategy positions it as a specialized importer of Ayurvedic & Herbal Products in Poland. This focus allows the company to build strong relationships with its Indian suppliers, potentially securing favorable terms and ensuring product quality. However, the high degree of concentration also exposes the company to risks associated with supply chain disruptions. To strengthen its competitive position, SVS Management Ltd could consider diversifying its supplier base and expanding its product portfolio within the Ayurvedic & Herbal Products category. This strategy would not only mitigate potential risks but also enable the company to offer a more comprehensive range of products to meet the evolving demands of the Polish market.

TransData Nexus Research · Verified DGFT customs dataMar 2026

Importing Pharmaceuticals into Poland — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Poland

1Regulatory Authority & Framework

In Poland, the Chief Pharmaceutical Inspectorate (Główny Inspektorat Farmaceutyczny, GIF) is the primary regulatory authority overseeing the manufacturing and import of medicinal products. According to the Pharmaceutical Law Act, activities related to the manufacture or import of medicinal products require authorization from the Chief Pharmaceutical Inspector. The GIF is responsible for issuing such authorizations and conducting inspections to ensure compliance with Good Manufacturing Practice (GMP) requirements. Additionally, the GIF supervises the protection and disposal of narcotics, psychotropic substances, and category 1 precursors, as stipulated in the Act on Prevention of Drug Abuse and related regulations. (archiwum.gif.gov.pl)

2Import Licensing & GMP

Importing medicinal products into Poland necessitates obtaining a license from the Chief Pharmaceutical Inspectorate. This license is granted based on compliance with the Pharmaceutical Law Act and associated regulations. The Chief Pharmaceutical Inspectorate conducts inspections to verify adherence to Good Manufacturing Practice (GMP) standards, ensuring that imported products meet quality, safety, and efficacy requirements. These inspections are typically conducted at least once every three years, with additional ad-hoc inspections possible if there are concerns about product quality or safety. (archiwum.gif.gov.pl)

3Quality & Labeling

Imported medicinal products must undergo batch testing to confirm their quality, safety, and efficacy. The Chief Pharmaceutical Inspectorate supervises the conditions of manufacture and import to ensure compliance with these standards. Labeling requirements include providing information in Polish, detailing the product's composition, dosage instructions, and any necessary warnings. Additionally, serialization mandates may apply to facilitate traceability and prevent counterfeit products from entering the market. These measures are in place to protect public health and ensure that consumers receive safe and effective medicinal products. (archiwum.gif.gov.pl)

4Recent Regulatory Changes

Between 2024 and 2026, Poland's Chief Pharmaceutical Inspectorate issued a decision interpreting the definition of "import" concerning medicinal products. The decision clarified that any activity involving the storage, quality control, or distribution of a medicinal product within Poland constitutes an import requiring authorization. This ruling emphasizes the need for entities involved in such activities to obtain the necessary licenses and comply with regulatory requirements. (cms.law)

TransData Nexus Research · Poland regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Buyer Matching: SVS Management Ltd identified across shipments using consignee name normalization.
2.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
3.Market Share: Calculated per product as SVS Management Ltd's capped value divided by total Indian exports for that product.
4.Shipment Count: Based on 13 individual customs records matching SVS Management Ltd.
5.Supplier Verification: SVS Management Ltd sources from 3 verified Indian suppliers across 232 formulations, confirmed from customs records.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2 Products Tracked

1 therapeutic categories

Expert-Reviewed

By pharmaceutical trade specialists

SVS Management Ltd

SVS Management Ltd — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to SVS Management Ltd?

What Formulations Does SVS Management Ltd Import?

What Products Does SVS Management Ltd Import?

Top Products by Import Value

SVS Management Ltd Therapeutic Categories — 1 Specializations

Import Portfolio — Top 2 by Import Value

Key Metrics

Top Categories

Indian Suppliers

SVS Management Ltd — Corporate Profile & Information

1Company Overview

2Distribution Network

Related Trade Data

Need Detailed Data?

3Industry Role

Supplier Relationship Intelligence — SVS Management Ltd

1Sourcing Concentration Analysis

2Supply Chain Resilience

3Strategic Implications

Importing Pharmaceuticals into Poland — Regulatory Framework

1Regulatory Authority & Framework

2Import Licensing & GMP

3Quality & Labeling

4Recent Regulatory Changes

SVS Management Ltd — Procurement Pattern Analysis

1Product Strategy

2Sourcing Profile

3Market Positioning

Seller's Guide — How to Become a Supplier to SVS Management Ltd

1Opportunity Assessment

2Requirements & Qualifications

3How to Approach

Frequently Asked Questions — SVS Management Ltd

What products does SVS Management Ltd import from India?

Who supplies pharmaceuticals to SVS Management Ltd from India?

What is SVS Management Ltd's total pharmaceutical import value?

What therapeutic categories does SVS Management Ltd focus on?

Get Full SVS Management Ltd Import Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Data Source & Methodology